Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubber
São Paulo, São Paulo, Brazilhubber.com.br ↗
- Ownership
- Private
- Employees
- ~125
- Development stage
- Other
01
Overview
Hubber is a Brazilian healthtech company that provides a comprehensive digital platform connecting the pharmaceutical industry, healthcare professionals, and patients. The company specializes in Patient Support Programs (PSP) and physician engagement, utilizing data-driven insights to optimize treatment adherence and market access. Hubber's ecosystem facilitates digital prescriptions, patient monitoring, and provides the life sciences sector with actionable data on the patient journey. By bridging the gap between stakeholders, the platform aims to improve clinical outcomes and streamline the delivery of healthcare services in the Latin American market.
- Industry
- Biomedical IT and Biomedical Data Platforms
Beyond the preview
Go deeper on Hubber.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hubber.